Exchange: NASDAQ·Updated 04:15 PM EST

UTHR News

News
all
press releases
United Therapeutics Corporation (UTHR) Presents at Jefferies Global Healthcare Conference 2026 Transcript
United Therapeutics Corporation (UTHR) Presents at Jefferies Global Healthcare Conference 2026 Transcript...
SeekingAlpha
United Therapeutics Corporation (UTHR) Presents at Jefferies Global Healthcare Conference 2026 Transcript
United Therapeutics Corporation (UTHR) Presents at Jefferies Global Healthcare Conference 2026 Transcript...
SeekingAlpha
More News
United Therapeutics (NASDAQ:UTHR) is preparing for a potential expansion of its TYVASO franchise into idiopathic pulmonary fibrosis, while its executives pointed to strong third-quarter sales and a pipeline of regulatory and clinical milestones at the UBS London Healthcare Conference. The company r...
MarketBeat
SGIOY vs. UTHR: Which Stock Is the Better Value Option?
Zacks
United Therapeutics Corporation (UTHR) Presents at UBS Global Biopharma Conference 2026 Transcript...
SeekingAlpha
United Therapeutics (NASDAQ:UTHR) has outperformed the market over the past 15 years by 6.56% on an annualized basis producing an average annual return of 19.5%. Currently, United Therapeutics has a marketread more...
Benzinga
Liquidia's Q3 earnings and revenues beat estimates as Yutrepia sales surge, while strong PAH demand and pipeline investments support growth.
Zacks
United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer, will provide an overview and update during fireside chat sessions at two upcoming investor conferences in London. UBS Global Biopharma Conference on Monday, November 16, 2026...
Business Wire
Although the revenue and EPS for United Therapeutics (UTHR) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that it has entered into an amendment with Arena Pharmaceuticals, Inc. (Arena), a subsidiary of Pfizer Inc., which eliminates all royalty obligations under its exclusive license agreement related to...
Business Wire
(RTTNews) - United Therapeutics Corp (UTHR) reported earnings for third quarter that Dropped, from the same period last year...
Nasdaq News: Markets

Advertisement|Remove ads.